Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Biophore India Pharmaceuticals Pvt Ltd

02 101GUERBET

03 4Jiangsu Hengrui Medicine

04 4Jodas Expoim Pvt. Ltd

05 38Mallinckrodt Pharmaceuticals

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBiophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Regulatory Info :

Registration Country : India

Ioversol

Brand Name :

Dosage Form : Injection

Dosage Strength : 240MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Biophore

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBiophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Regulatory Info :

Registration Country : India

Ioversol

Brand Name :

Dosage Form : Injection

Dosage Strength : 300MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Biophore

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBiophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Regulatory Info :

Registration Country : India

Ioversol

Brand Name :

Dosage Form : Injection

Dosage Strength : 320MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Biophore

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBiophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Regulatory Info :

Registration Country : India

Ioversol

Brand Name :

Dosage Form : Injection

Dosage Strength : 350MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Biophore

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

IOVERSOL

Brand Name : OPTIRAY 320

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 68%

Packaging :

Approval Date : 1988-12-30

Application Number : 19710

Regulatory Info : RX

Registration Country : USA

blank

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

IOVERSOL

Brand Name : OPTIRAY 240

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 51%

Packaging :

Approval Date : 1988-12-30

Application Number : 19710

Regulatory Info : DISCN

Registration Country : USA

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

IOVERSOL

Brand Name : OPTIRAY 160

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 34%

Packaging :

Approval Date : 1988-12-30

Application Number : 19710

Regulatory Info : DISCN

Registration Country : USA

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

IOVERSOL

Brand Name : OPTIRAY 300

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 64%

Packaging :

Approval Date : 1992-01-22

Application Number : 19710

Regulatory Info : RX

Registration Country : USA

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

IOVERSOL

Brand Name : OPTIRAY 350

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 74%

Packaging :

Approval Date : 1992-01-22

Application Number : 19710

Regulatory Info : RX

Registration Country : USA

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

IOVERSOL

Brand Name : OPTIRAY 240

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 51%

Packaging :

Approval Date : 1998-05-28

Application Number : 20923

Regulatory Info : DISCN

Registration Country : USA

blank

11

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

IOVERSOL

Brand Name : OPTIRAY 320

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 68%

Packaging :

Approval Date : 1998-05-29

Application Number : 20923

Regulatory Info : RX

Registration Country : USA

blank

12

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

IOVERSOL

Brand Name : OPTIRAY 350

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 74%

Packaging :

Approval Date : 1998-05-28

Application Number : 20923

Regulatory Info : RX

Registration Country : USA

blank

13

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

IOVERSOL

Brand Name : OPTIRAY 300

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 64%

Packaging :

Approval Date : 1999-05-13

Application Number : 20923

Regulatory Info : RX

Registration Country : USA

blank

14

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

joversol

Brand Name : Optiray

Dosage Form : INJEKTIONS-/INFUSIONSVÄTSKA, LÖSNING

Dosage Strength : 240 MG I/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

15

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

joversol

Brand Name : Optiray

Dosage Form : INJEKTIONS-/INFUSIONSVÄTSKA, LÖSNING

Dosage Strength : 320 MG I/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

16

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

joversol

Brand Name : Optiray

Dosage Form : INJEKTIONS-/INFUSIONSVÄTSKA, LÖSNING

Dosage Strength : 300 MG I/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

17

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

joversol

Brand Name : Optiray

Dosage Form : INJEKTIONS-/INFUSIONSVÄTSKA, LÖSNING

Dosage Strength : 350 MG I/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

18

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

joversol

Brand Name : Optiray

Dosage Form : INJEKTIONS-/INFUSIONSVÄTSKA, LÖSNING

Dosage Strength : 320 MG I/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

19

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

joversol

Brand Name : Optiray

Dosage Form : INJEKTIONS-/INFUSIONSVÄTSKA, LÖSNING

Dosage Strength : 300 MG I/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

20

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

joversol

Brand Name : Optiray

Dosage Form : INJEKTIONS-/INFUSIONSVÄTSKA, LÖSNING

Dosage Strength : 350 MG I/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank